Leafly has Unique Expansion Plans for the German Medical Marijuana System


Leafly has Unique Expansion Plans for the German Medical Marijuana System

My favorite part of helping organize conferences like the International Cannabis Business Conference is learning from cutting edge activists, entrepreneurs and businesses from around the world. One of my biggest goals for the ICBC in Berlin, which has attendees from more than 35 countries in attendance, is highlighting the German medical cannabis provision that covers patients’ medicinal marijuana thru insurance coverage.

I was fortunate to have the opportunity to catch up with Leafly’s Linn Baumgardt who was literally on her way to Berlin. Linn is speaking on Wednesday, April 12th, at noon on the ICBC’s Consumer and Tech Branding Panel. Leafly, of course, has been a leader in helping patients and consumers learn about cannabis strains and dispensaries around the world and it was a pleasure learning a bit more about the company’s plans for Germany.

Anthony Johnson: What is your position and duties with Leafly?

Linn Baumgardt: I’m the Director of Strategic Initiatives. I’m responsible for the expansion of Leafly into Germany, a burgeoning medical cannabis country that is helping the global movement to legalize medical cannabis in Europe, and around the world.

What are Leafly’s plans for the Germany expansion?

Leafly.com is available in every country. However, we will be launching Leafly.de in May 2017. Leafly.de will look and function differently from the US website, as there are currently no dispensaries in Germany.

Medical cannabis is a new topic to many Germans, and Leafly.de will serve as a competent and trustworthy informational resource for German speaking patients, doctors, pharmacists, and adults who are interested in learning more about the topic.

Germany’s plan is to start having medical cannabis covered by health insurance, do you think that this would be a good approach for other countries?

It will be interesting to see how this will be implemented by doctors and health insurers. Germany’s health insurers may cover medical cannabis prescriptions for the “seriously ill” as stated in the new law. Rather than creating a new legal category for cannabis (the way US states and Canada are doing it,) Germany is modifying their narcotics prescription medication law to include cannabis. If other countries go down the same path as Germany, it would make sense for them to look at what is working in the German system and adapt similar practices accordingly.

 Have you heard good feedback from patients and customers about Leafly’s services?

One of the reasons we are launching Leafly.de is that we are hearing of an overwhelming need for information from German patients, medical practitioners, media, and regulators. While there are activist groups in Germany that have been very passionate and vocal about the topic for a long time, for mainstream Germans this is new territory. We are very excited to launch Leafly.de and get feedback on what our site visitors like and what they would like us to add on and develop.

Thank you very much for your time and I look forward to meeting you and hearing more about Leafly’s innovative  expansion plan for Germany. 

Thank you, see you soon!

Anthony Johnson

Anthony, a longtime cannabis law reform advocate, was Chief Petitioner and co-author of Measure 91, Oregon's cannabis legalization effort. He served as director of both the New Approach Oregon and Vote Yes on 91 PACs, the political action committees responsible for the state's legalization campaign. As director of New Approach Oregon, Anthony continues to work towards effectively implementing the cannabis legalization system while protecting small business owners and the rights of patients. He sits on the Oregon Marijuana Rules Advisory Committee and fights for sensible rules at the legislature as well as city councils and county commissions across the state. Anthony helps cannabis business comply with Oregon's laws and advises advocates across the country. He also serves as content director of both the International Cannabis Business Conference and the Oregon Marijuana Business Conference, helping share the vision of moving the cannabis industry forward in a way that maintains the focus on keeping people out of prison and protecting patients. He was a member of the Oregon Health Authority Rules Advisory Committee, assisting the drafting of the administrative rules governing Oregon’s state-licensed medical marijuana facilities. He first co-authored and helped pass successful marijuana law reform measures while a law student at the University of Missouri-Columbia School of Law. He passed the Oregon Bar in 2005 and practiced criminal defense for two years before transitioning to working full-time in the political advocacy realm. His blogs on Marijuana Politics are personal in nature and don't speak for or reflect the opinions of any group or organization.